DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹402 Cr | ₹464 Cr | ₹470 Cr | ₹500 Cr | ₹274 Cr |
What is the latest Total Current Liabilities ratio of DR LAL PATHLABS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹402 Cr |
Mar2024 | ₹464 Cr |
Mar2023 | ₹470 Cr |
Mar2022 | ₹500 Cr |
Mar2021 | ₹274 Cr |
How is Total Current Liabilities of DR LAL PATHLABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹402 Cr | -13.21 | |
Mar2024 | ₹464 Cr | -1.31 | |
Mar2023 | ₹470 Cr | -6.05 | |
Mar2022 | ₹500 Cr | 82.29 | |
Mar2021 | ₹274 Cr | - |
Compare Total Current Liabilities of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹24,372.0 Cr | -2.1% | 3.1% | 5.5% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹114,898.0 Cr | -1.7% | 1.4% | 37.5% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹99,606.1 Cr | -1% | 0.2% | 12.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹57,286.2 Cr | -0% | 11.6% | 57.5% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹38,915.4 Cr | 4.6% | 10.2% | 55.1% | Stock Analytics | |
GLOBAL HEALTH | ₹31,484.3 Cr | -1.1% | -1.5% | -7.2% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -2.1% |
3.1% |
5.5% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses